Show summary Hide summary
Measles’ return to the United States is having consequences beyond health: it threatens the country’s formal elimination status and is generating a growing economic burden, according to a new Johns Hopkins modelling tool. The researchers estimate the 2026 outbreaks may already have cost the U.S. tens of millions of dollars in public health work, lost wages and medical care.
A widening outbreak and a potential loss of status
Health organizations have raised the alarm as measles cases climbed to levels not seen in decades. A Pan American Health Organization review this week is expected to strip the U.S. of its official elimination status after infections surged.
Engadget launches search for new writers
I can’t access the link. Please paste the exact original headline (or the short text you want rewritten). Once you do, I’ll create a new, original, U.S.-style English headline following your rules.

Through early November 2026, more than 5,100 cases were reported nationwide. States have confirmed eight deaths so far this year — six in Pennsylvania, one in New York and one in Wisconsin — underscoring the renewed severity of the virus.
A nearly $83 million estimate for 2026
Using updated, state-specific inputs, a Johns Hopkins tool calculates an economic impact for 2026 of about $83 million. The breakdown in that estimate attributes roughly $56 million to the public health response, nearly $25 million to lost productivity, and more than $1.8 million to direct medical costs.
The same tool applied to 2025 — when 2,289 confirmed cases were reported — yields an estimated cost exceeding $37 million, illustrating how quickly expenses rise as outbreaks grow.
How costs are calculated
The model incorporates recent data on hospital costs, wages and state-level financing to estimate three major cost categories: outbreak investigation and containment, wages lost when people miss work, and medical treatment for those who become ill.
Researchers caution the numbers are estimates rather than a definitive ledger of spending. Still, the figures are intended to show the scale of resources mobilized to contain measles — a largely preventable infection — and the economic consequences of declining childhood vaccination rates.
Fixed costs versus per-case expenses
An earlier study from the Johns Hopkins team reviewed historical outbreak reports and found that much of the expense is front-loaded. The researchers estimated nearly $298,000 in fixed response costs plus about $16,300 for each additional case, and calculated an historical average of roughly $59,000 in public health response costs per case. That analysis excluded productivity losses because past reports did not consistently capture them, and it drew on data from particularly costly outbreaks such as New York City in 2019.
State-level variation
Costs vary significantly by state because hospital billing rates, wage levels and public health funding differ. For example, New York’s 48 confirmed cases in 2025 are estimated by the tool to have cost about $1.1 million — including nearly $749,000 for public health work, $333,000 in productivity losses and about $24,500 in medical expenses.

By contrast, Texas — which reported 803 cases in 2025, the largest outbreak that year — is estimated to have incurred close to $13 million in total costs: around $9 million for public health response, $4 million in lost productivity and roughly $288,000 in direct medical care.
Those differences reflect inputs such as average inpatient stay costs and local wages. In New York, for instance, the model used an approximate inpatient daily cost of $4,200 and a minimum wage of $16 per hour.
Quarantines, missed work and the ripple effect
Indirect costs can escalate quickly because measles is highly contagious. A single infected person can expose dozens of contacts who may need to quarantine while officials determine infection status, producing economic loss even when those contacts never develop the disease.
Modeling from other researchers examined a hypothetical 1,500-case outbreak and estimated a total cost near $90 million, with about $26 million attributed to lost productivity. One analysis suggests the average quarantined person represents nearly $300 in lost productivity, so a case that prompts 40–50 quarantines could translate into roughly $12,000–$15,000 in productivity losses alone.
Those secondary costs help explain why some economists argue that vaccination programs remain far cheaper than the economic fallout of outbreaks. Local health departments often absorb much of the immediate burden, diverting staff and resources from other public health duties when an outbreak occurs.
Implications for planning and funding
Researchers behind the tool say the estimates can help state and local officials anticipate the resources needed to respond to outbreaks as cases rise. Public health leaders face the trade-off of investing in routine vaccination and prevention versus repeatedly redirecting limited capacity to emergency response.
As measles returns, the financial strain on health systems and communities may grow unless immunization coverage improves and funding for outbreak preparedness is strengthened.











